Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Yan‐ru Qin"'
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 2262-2280 (2023)
Abstract Cutaneous melanoma represents around over 90% of all melanoma. With more effective treatments able to extend patients' survival, health‐related quality of life (HRQOL) is increasingly becoming an important endpoint in cancer clinical trial
Externí odkaz:
https://doaj.org/article/579a12a85ed34e7f9bbcdd202c7c529a
Autor:
Wen Wen Xu, Long Liao, Wei Dai, Can-Can Zheng, Xiang-Peng Tan, Yan He, Qi-Hua Zhang, Zhi-Hao Huang, Wen-You Chen, Yan-Ru Qin, Kui-Sheng Chen, Ming-Liang He, Simon Law, Maria Li Lung, Qing-Yu He, Bin Li
Publikováno v:
EBioMedicine, Vol 92, Iss , Pp 104587- (2023)
Summary: Background: Metastasis is one of the most lethal hallmarks of esophageal squamous cell carcinoma (ESCC), yet the mechanisms remain unclear due to a lack of reliable experimental models and systematic identification of key drivers. There is u
Externí odkaz:
https://doaj.org/article/aeceea20bec3401eb5107b3fab3e3b56
Autor:
Haibo Qiu, Xu Zhang, Jiali Qi, Jiangwen Zhang, Yin Tong, Lei Li, Li Fu, Yan-Ru Qin, Xinyuan Guan, Liyi Zhang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-24 (2022)
Abstract Background Cancer-associated fibroblast (CAF) is an ideal target for cancer treatment. Recent studies have focused on eliminating CAFs and their effects by targeting their markers or blocking individual CAF-secreted factors. However, these s
Externí odkaz:
https://doaj.org/article/f4bdca23331b499ba9d71306ec3ed6fc
Autor:
Xiao‐Dong Zhu, Ming‐Zhu Huang, Yu‐Sheng Wang, Wan‐Jing Feng, Zhi‐Yu Chen, Yi‐Fu He, Xiao‐Wei Zhang, Xin Liu, Chen‐Chen Wang, Wen Zhang, Jie‐Er Ying, Jun Wu, Lei Yang, Yan‐Ru Qin, Jian‐Feng Luo, Xiao‐Ying Zhao, Wen‐Hua Li, Zhe Zhang, Li‐Xin Qiu, Qi‐Rong Geng, Jian‐Ling Zou, Jie‐Yun Zhang, Hong Zheng, Xue‐Feng Song, Shu‐Sheng Wu, Cheng‐Yan Zhang, Zhe Gong, Qin‐Qin Liu, Xiao‐Feng Wang, Qi Xu, Qi Wang, Jian‐Mei Ji, Jian Zhao, Wei‐Jian Guo
Publikováno v:
Cancer Communications, Vol 42, Iss 4, Pp 314-326 (2022)
Abstract Background There is no consensus on whether triplet regimen is better than doublet regimen in the first‐line treatment of advanced gastric cancer (AGC). We aimed to compare the efficacy and safety of oxaliplatin plus capecitabine (XELOX) a
Externí odkaz:
https://doaj.org/article/3847a66d6c7b4f0a892d3bcfe99399f3
Autor:
Ling-Ling Lei, Xin Song, Xue-Ke Zhao, Rui-Hua Xu, Meng-Xia Wei, Lin Sun, Pan-Pan Wang, Miao-Miao Yang, Jing-Feng Hu, Kan Zhong, Wen-Li Han, Xue-Na Han, Zong-Min Fan, Ran Wang, Bei Li, Fu-You Zhou, Xian-Zeng Wang, Li-Guo Zhang, Qi-De Bao, Yan-Ru Qin, Zhi-Wei Chang, Jian-Wei Ku, Hai-Jun Yang, Ling Yuan, Jing-Li Ren, Xue-Min Li, Li-Dong Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
BackgroundThe impact of hospital volume on the long-term survival of esophageal squamous cell carcinoma (ESCC) has not been well assessed in China, especially for stage I–III stage ESCC. We performed a large sample size study to assess the relation
Externí odkaz:
https://doaj.org/article/fd1ac2753c234bad9e25cefc8dd7ae10
Autor:
Zhuo Li, Meng‐Yan Li, Ling‐Ling Wang, Lei Li, Qing‐Yun Chen, Ying‐Hui Zhu, Yan Li, Yan‐ru Qin, Xin‐Yuan Guan
Publikováno v:
Thoracic Cancer, Vol 12, Iss 24, Pp 3370-3379 (2021)
Abstract Background Esophageal cancer is currently the eighth most common tumor in the world and a leading cause of cancer death. SULT2B1 plays crucial roles in tumorigenesis. The purpose of this study is to explore the role of SULT2B1 in esophageal
Externí odkaz:
https://doaj.org/article/d26a0c6d67944e32b0a902b4e181dfb6
Autor:
Wen Wen Xu, Can-Can Zheng, Qian Zuo, Jun-Qi Li, Pan Hong, Yan-Ru Qin, Xin-Yuan Guan, Qing-Yu He, Hua-Xin Liao, Bin Li
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/7336cc43efc049909f64a1950e0acb73
Autor:
Zhong-Kun Xia, Wei Wang, Jian-Ge Qiu, Xi-Nan Shi, Hong-Jian Li, Rong Chen, Kun-Bin Ke, Chao Dong, Ying Zhu, Shi-Guo Wu, Rong-Ping Zhang, Zhuo-Ran Meng, Hui Zhao, Peng Gu, Kwong-Sak Leung, Man-Hon Wong, Xiao-Dong Liu, Feng-Mei Zhou, Jian-Ying Zhang, Ya-Ting Yao, Si-Jia Wang, Chun-Yang Zhang, Yan-Ru Qin, Marie Chia-mi Lin, Bing-Hua Jiang
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Hepatocellular carcinoma (HCC) is a lethal malignancy lacking effective treatment. The Cyclin-dependent kinases 4/6 (CDK4/6) and PI3K/AKT signal pathways play pivotal roles in carcinogenesis and are promising therapeutic targets for HCC.
Externí odkaz:
https://doaj.org/article/8c577fa7534e405a9a6ce01a297274b9
Autor:
Ya-Ping Gao, Lei Li, Jie Yan, Xiao-Xia Hou, Yong-Xu Jia, Zhi-Wei Chang, Xin-Yuan Guan, Yan-Ru Qin
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies with poor prognosis and lack of effective targeted therapies. In this study, we investigated the tumor suppressive role of the cell death inducing DFF like effector A (C
Externí odkaz:
https://doaj.org/article/d5dd3a61bed540198ea09fc37df8e6ea
Autor:
Wen Wen Xu, Zhi‐Hao Huang, Long Liao, Qi‐Hua Zhang, Jun‐Qi Li, Can‐Can Zheng, Yan He, Ting‐Ting Luo, Yang Wang, Hui‐Fang Hu, Qian Zuo, Wen‐You Chen, Qing‐Sheng Yang, Jian‐Fu Zhao, Yan‐Ru Qin, Li‐Yan Xu, En‐Min Li, Hua‐Xin Liao, Bin Li, Qing‐Yu He
Publikováno v:
Advanced Science, Vol 7, Iss 16, Pp n/a-n/a (2020)
Abstract Metastasis accounts for 90% of cancer death worldwide, and effective therapeutic strategies are lacking. The aim of this work is to identify the key drivers in tumor metastasis and screen therapeutics for treatment of esophageal squamous cel
Externí odkaz:
https://doaj.org/article/9a02d44b2de7427dbd59dc12684ef361